These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16738843)

  • 1. Deflazacort induced stronger immunosuppression than expected.
    Gonzalez-Castañeda RE; Castellanos-Alvarado EA; Flores-Marquez MR; Gonzalez-Perez O; Luquin S; Garcia-Estrada J; Ramos-Remus C
    Clin Rheumatol; 2007 Jun; 26(6):935-40. PubMed ID: 16738843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisone induces cognitive dysfunction, neuronal degeneration, and reactive gliosis in rats.
    Ramos-Remus C; González-Castañeda RE; González-Perez O; Luquin S; García-Estrada J
    J Investig Med; 2002 Nov; 50(6):458-64. PubMed ID: 12425433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone induces anxiety and glial cerebral changes in rats.
    Gonzalez-Perez O; Ramos-Remus C; Garcia-Estrada J; Luquin S
    J Rheumatol; 2001 Nov; 28(11):2529-34. PubMed ID: 11708428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
    Aicardi G; Milani S; Imbimbo B; Vignolo M; Di Battista E; Gusmano R; Terragna A; Cordone G; Cottafava F; Coppo R
    Calcif Tissue Int; 1991 Apr; 48(4):283-7. PubMed ID: 2059880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
    Aicardi G; Benso L; Vignolo M; Terragna A; Verrina E; Cordone G; Coppo R; Sernia O; Sardella ML; Di Battista E
    Br J Rheumatol; 1993 May; 32 Suppl 2():39-43. PubMed ID: 8495279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
    Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
    Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
    Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome.
    Broyer M; Terzi F; Lehnert A; Gagnadoux MF; Guest G; Niaudet P
    Pediatr Nephrol; 1997 Aug; 11(4):418-22. PubMed ID: 9260237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.
    Scudeletti M; Puppo F; Lanza L; Mantovani L; Bosco O; Iudice A; Imbimbo B; Indiveri F
    Eur J Clin Pharmacol; 1993; 45 Suppl 1():S29-34. PubMed ID: 8313931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency ratio--a brief synopsis.
    Avioli LV
    Br J Rheumatol; 1993 May; 32 Suppl 2():24-6. PubMed ID: 8495276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head to head comparison of adverse effects and efficacy between high dose deflazacort and high dose prednisolone in systemic lupus erythematosus: a prospective cohort study.
    Ganapati A; Ravindran R; David T; Yadav B; Jeyaseelan V; Jeyaseelan L; Danda D
    Lupus; 2018 May; 27(6):890-898. PubMed ID: 29320974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro improvement of chlorambucil-induced cytotoxicity by deflazacort and 6-methylprednisolone in B-cell chronic lymphocytic leukaemia.
    Morabito F; Callea I; Irrera G; Cartisano G; Dattola A; Rodinò A; Brugiatelli M
    Eur J Haematol; 1997 May; 58(5):301-6. PubMed ID: 9222284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deflazacort in the treatment of haematologic disorders.
    Gobbi M; Scudeletti M
    Eur J Clin Pharmacol; 1993; 45 Suppl 1():S25-8. PubMed ID: 8313930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.
    Bello L; Gordish-Dressman H; Morgenroth LP; Henricson EK; Duong T; Hoffman EP; Cnaan A; McDonald CM;
    Neurology; 2015 Sep; 85(12):1048-55. PubMed ID: 26311750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the synthetic glucocorticoid, deflazacort, on body growth, pulsatile secretion of GH and thymolysis in the rat.
    Latta K; Krieg RJ; Hisano S; Veldhuis JD; Chan JC
    Eur J Endocrinol; 1999 May; 140(5):441-6. PubMed ID: 10229911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
    Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
    Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with deflazacort in children and adolescents after renal transplantation.
    Schärer K; Feneberg R; Klaus G; Paschen C; Wüster C; Mehls O; Schaefer F
    Pediatr Nephrol; 2000 Jun; 14(6):457-63. PubMed ID: 10872183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of lymphocyte subpopulations in chronic autoimmune inflammatory rheumatic diseases. II. Polymyalgia rheumatica: behaviour of lymphocyte subpopulations during treatment with two different corticosteroids].
    Coaccioli S; Pinoca F; Giuliani M; Sabatini C; Puxeddu A
    Minerva Med; 2005 Oct; 96(5):379-87. PubMed ID: 16227953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Therapy Deflazacort/Doxycyclyne Is Better Than Deflazacort Monotherapy to Alleviate Cardiomyopathy in Dystrophin-Deficient mdx Mice.
    Pereira JA; Mauricio AF; Marques MJ; Neto HS
    J Cardiovasc Pharmacol Ther; 2017 Sep; 22(5):458-466. PubMed ID: 28793824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.